Work Description
Title: Literature searches for "Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis" Open Access Deposited
Attribute | Value |
---|---|
Methodology |
|
Description |
|
Creator | |
Creator ORCID iD | |
Depositor |
|
Depositor creator |
|
Contact information | |
Discipline | |
Keyword | |
Date coverage |
|
Citations to related material |
|
Resource type | |
Curation notes |
|
Last modified |
|
Published |
|
Language | |
DOI |
|
License |
To Cite this Work:
(2022). Literature searches for "Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis" [Data set], University of Michigan - Deep Blue Data. https://doi.org/10.7302/07jh-ht69
(2022). Literature searches for "Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis" [Data set], University of Michigan - Deep Blue Data. https://doi.org/10.7302/07jh-ht69
Relationships
Files (Count: 2; Size: 51.8 KB)
Thumbnailthumbnail-column | Title | Original Upload | Last Modified | File Size | Access | Actions |
---|---|---|---|---|---|---|
|
CkdG2Agents_LiteratureSearches_2...9.pdf | 2022-05-24 | 2022-05-24 | 48.4 KB | Open Access |
|
|
ReadMe_20220524.txt | 2022-05-24 | 2022-05-24 | 3.31 KB | Open Access |
|
Date: 24 May 2022
Dataset Title: Literature searches for "Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis"
Dataset Creator: M P MacEachern
Dataset Contact: markmac@umich.edu
Funding: None
Key Points: This dataset includes database searches to support a systematic review and meta-analysis.
Introduction:
The literature searches contained in this deposit were designed to support a systematic review project on the risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease recieving a group II gadolinium-based contrast agent. The intent of the searches is to identify all relevant studies and data related to the topic. In the dataset there are searches for the following databases: Ovid MEDLINE, Elsevier Embase, Clarivate Web of Science, and Wiley Cochrane Central Register of Controlled Trials.
Methodology: The searches are presented in their entirety. They combine chronic kidney disease AND gadolinium terms. The searches were run in 2019 and the research was published in JAMA Internal Medicine in 2020. The searches yielded 2700 citations after duplicates were removed in Endnote X8.
Files:
All literature searches for the project = CkdG2Agents_LiteratureSearches_20190129.pdf
Requirements:
The searches were designed to work in the following citation databases: Ovid MEDLINE, Elsevier Embase, Clarivate Web of Science, and Wiley Cochrane Central Register of Controlled Trials. The terms can be adapted to other databases as well, as long as the search syntax is adjusted appropriately. These databases are proprietary. They may be available through libraries and educational institutions. No installation of software is necessary.
Using the searches:
* Open the pdf file with the searches
* Paste the searches into the corresponding databases. If a line is prefaced with a number (such as 1), treat the following text as an isolated search statement. Each database search (with the exception of Open Grey) consists of 3 independent search statements.
* The results will appear after you run the searches. The results numbers are included in the dataset. Note that the search result numbers reported in the dataset will be lower than present day because of the expanding coverage of time.
Related Publication:
Woolen, S. A., Shankar, P. R., Gagnier, J. J., MacEachern, M. P., Singer, L., & Davenport, M. S. (2020). Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis. JAMA internal medicine, 180(2), 223230. https://doi.org/10.1001/jamainternmed.2019.5284
Use and Access:
http://creativecommons.org/licenses/by-nc/4.0/
To Cite the Dataset:
MacEachern, M. Literature searches for "Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis" [Data set], University of Michigan - Deep Blue Data.
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to contact us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.